Back to School: How biopharma can reboot drug development. Access exclusive analysis here
BioLineRx Ltd. (Tel Aviv:BLRX; NASDAQ:BLRX) granted Jiangsu Chia-Tai Tianqing Pharmaceutical Co. Ltd.
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury